<DOC>
	<DOCNO>NCT00151502</DOCNO>
	<brief_summary>The purpose study find atovastatin , take cholinesterase inhibitor , effective treat Alzheimer 's disease .</brief_summary>
	<brief_title>To Evaluate Safety Effectiveness Atorvastatin Plus Cholinesterase Inhibitor AD Patients .</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>Diagnostic evidence probable Alzheimer 's disease consistent NINCDS/ADRDA DSM IV criterion . Subject 's MiniMental Status Examination Score ( MMSE ) must range 13 25 ( inclusive ) Screening . Subjects dementia due cause Alzheimer 's disease . Any condition , , investigator 's judgment might increase risk subject decrease reliability data require meet objective study .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>